Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: Patient's choice"

George Woody; Douglas Bruce; P. Todd Korthuis; Sumedha Chhatre; Maureen Hillhouse; Petra Jacobs; James Sorensen; Andrew J. Saxon; Sabrina Poole; David Metzger; Walter Ling

doi:10.1097/qai.0000000000000344

Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: Patient's choice"

George Woody, Douglas Bruce, P. Todd Korthuis, Sumedha Chhatre, Maureen Hillhouse, Petra Jacobs, James Sorensen, Andrew J. Saxon, Sabrina Poole, David Metzger, Walter Ling

Department of Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	e142-e143
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	67
Issue number	5
DOIs	https://doi.org/10.1097/qai.0000000000000344
State	Published - 2014

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

Access to Document

10.1097/qai.0000000000000344

Cite this

@article{8e5a565ffbc04e22906bfa8bfe1e6996,

title = "Authors' reply: {"}Risk reduction with buprenorphine-naloxone and methadone: Patient's choice{"}",

author = "George Woody and Douglas Bruce and Korthuis, {P. Todd} and Sumedha Chhatre and Maureen Hillhouse and Petra Jacobs and James Sorensen and Saxon, {Andrew J.} and Sabrina Poole and David Metzger and Walter Ling",

year = "2014",

doi = "10.1097/qai.0000000000000344",

language = "English (US)",

volume = "67",

pages = "e142--e143",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Authors' reply

T2 - "Risk reduction with buprenorphine-naloxone and methadone: Patient's choice"

AU - Woody, George

AU - Bruce, Douglas

AU - Korthuis, P. Todd

AU - Chhatre, Sumedha

AU - Hillhouse, Maureen

AU - Jacobs, Petra

AU - Sorensen, James

AU - Saxon, Andrew J.

AU - Poole, Sabrina

AU - Metzger, David

AU - Ling, Walter

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84925553340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925553340&partnerID=8YFLogxK

U2 - 10.1097/qai.0000000000000344

DO - 10.1097/qai.0000000000000344

M3 - Letter

C2 - 25243431

AN - SCOPUS:84925553340

SN - 1525-4135

VL - 67

SP - e142-e143

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 5

ER -

Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: Patient's choice"

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this